Given the significant link between EIF4A2 and RBM17 in AML, we next tested whether restoring EIF4A2 in a form impervious to splicing, could rescue any biological effects caused by RBM17 knockdown. The gene discussed is EIF4A2; the disease is acute myeloid leukemia.